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Abstract
Background
This study aimed to determine the risk of diabetes mellitus (DM) on incidence of out-of-hos-
pital cardiac arrest (OHCA) and to investigate whether difference in effects of DM between
therapeutic methods was observed.
Methods
This study was a case-control study using the Cardiac Arrest Pursuit Trial with Unique Reg-
istration and Epidemiologic Surveillance (CAPTURES) project database and 2013 Korean
Community Health Survey (CHS). Cases were defined as EMS-treated adult (18 year old
and older) OHCA patients with presumed cardiac etiology collected at 27 emergency
departments from January to December 2014. OHCA patients whose arrest occurred at
nursing homes or clinics and cases with unknown information on DM were excluded. Four
controls were matched to one case with strata including age, gender, and county from the
Korean CHS database. Multivariable conditional logistic regression analysis was conducted
to estimate the risk of DM and treatment modality on incidence of OHCA.
Results
Total 1,386 OHCA patients and 5,544 community-based controls were analyzed. A total of
370 (26.7%) among cases and 860 (15.5%) among controls were diagnosed with DM. DM
was associated with increasing risk of OHCA (AOR: 1.92 (1.65–2.24)). By DM treatment
modality comparing with non-DM group, AOR (95% CI) was the highest in non-pharmaco-
therapy only group (4.65 (2.00–10.84)), followed by no treatment group (4.17 (2.91–5.96)),
insulin group (2.69 (1.82–3.96)), and oral hypoglycemic agent group (1.55 (1.31–1.85)).
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Conclusion
DM increased the risk of OHCA, which was the highest in the non-pharmacotherapy group
and decreased in magnitude with pharmacotherapy.
Introduction
The overall public health burden of out-of-hospital cardiac arrest (OHCA) continues to
increase due to simultaneous growth of cardiovascular comorbidities prevalence along with the
aging population [1, 2]. Despite the development of intra-resuscitation and post-resuscitation
care, the survival rate of OHCA remains low and neurological outcome is often impaired [3]. A
better understanding of high risk groups of cardiac arrest especially in relation to cardiovascu-
lar comorbidities may provide the basis to develop and strategize prevention methods to
decrease the burden of OHCA.
Diabetes mellitus (DM) is a well-established risk factor of cardiovascular comorbidities
including coronary heart disease and ischemic stroke [4–6]. DM is also associated with
increased risk for cardiac arrest by means of micro- and macro-vascular processes, elevating
arrhythmogenic potential occurring as a result of diabetes-related autonomic neuropathy,
increasing susceptibility to atherosclerosis and prevalence of atherogenic risk factors such as
hypertension, dyslipidemia, obesity, and metabolic syndrome, hypercoagulable status second-
ary to DM, and diabetic cardiomyopathy [7–12].
The worldwide prevalence of DM has been dramatically increasing over time and is esti-
mated to be about 8% among adults in 2014, where the heaviest burden lies in the population
of more than 65 years of age [1, 13–15]. In addition, the prevalence of prediabetes with
impaired glucose tolerance and/or impaired fasting glycaemia has also been on the rise, dis-
playing a positive slope with increasing age. [1, 5]. Given the large number of diabetic patients
worldwide, the absolute number of cardiac arrests attributable to DM is expected to be onerous
and requires further investigation [1, 7].
Although a number of risk factors have been explicated in prior, whether and how the risk
factors pose any different effect on OHCA incidence remains as a challenge to be understood.
DM is a well-known independent risk factor for OHCA [9, 12, 16]; however, the variation of
the risk of DM depending on the therapeutic methods on OHCA incidence is yet to be clarified.
This study aimed to determine the risk of DM on OHCA incidence and to investigate whether
the effects of DM on OHCA incidence were different across various treatment modality.
Materials and Methods
Study design and data source
This study was a case-control study using the Cardiac Arrest Pursuit Trial with Unique Regis-
tration and Epidemiologic Surveillance (CAPTURES) project database in Korea. The CAP-
TURES project was a prospective hospital-based patient cohort study, conducted from January
to December 2014 at 27 emergency departments (EDs) (9 level 1 EDs and 18 level 2 EDs). This
prospective multicenter project aimed to identify the risk factors of OHCA incidence and to
evaluate determinants of the prognosis with long-term follow up. The CAPTURES project was
subjected to patients with OHCA transported to the study EDs by emergency medical service
(EMS) with resuscitation efforts (EMS-treated OHCA) and patients who had a presumed car-
diac etiology as identified by emergency physicians in each ED. The project excluded the
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patients with terminal illness, under hospice care, with pregnancy, living alone or homeless
without reliable information source, and a ‘Do Not Resuscitate’ card. OHCA patients of non-
cardiac etiology, including trauma, drowning, poisoning, burn, asphyxia, or hanging, were also
excluded.
The CAPTURES registry included patient’s socio-demographic information, health behav-
iors, past medical history, physical and emotional stress, EMS and ED information using
Utstein template, laboratory test, cardiac examination, and short and long-term outcomes.
Emergency physicians at each study ED collected the information using structured survey
papers during a face-to-face interview with the patients’ family. Study coordinators at each
study ED gathered laboratory test and cardiac examination results via medical record review
and contacted the patients’ family members to conduct telephone interview to survey long-
term outcomes after 6 and 12 months. Collected data were inputted and transferred to the cen-
tral data server using EpiData version 3.1 (The EpiData Association, Denmark, Europe). All
outliers or incorrect values were filtered by this data entry system.
The project quality management committee (QMC), which consisted of emergency physi-
cians, epidemiologists, cardiologists, statistical experts, and medical record review experts,
trained all study coordinators and investigators in each ED prior to joining the project. Addi-
tionally, the QMC gave feedback to study site coordinators on quality management of the
CAPTURES data through monthly meetings. In order to obtain more comprehensive knowl-
edge and maintain supervised information procurement, the study coordinators consulted the
emergency physicians in the QMC for clarification when they were unable to objectively define
a coding element.
Community-based controls were selected based on data from the 2013 Korean Community
Health Survey (CHS) as conducted by the Korea CDC between September and November
2013. The Korean CHS is a nationwide, community-based, and cross-sectional household-level
survey performed annually. The survey of 247 questionnaire items was conducted in 253 coun-
ties and aimed to gather reliable health-related information on acute and chronic diseases,
health care utilization, health behaviors, quality of life, socio-environmental factors, and demo-
graphic information of responders.
A total of 220,258 participants completed the Korean CHS survey in 2013. The respondents
were members of representatively selected households in 253 counties, which were sampled
using probability proportional to size systematic sampling method and square root propor-
tional allocation. All adult members who were 19 years old or older of the selected households
were eligible and were recruited to complete the survey by each county health authority. An
average of 920 adults in each county participated in the survey. All surveys were conducted by
trained interviewers, who administered a face-to-face interview using structured survey papers
and followed a strong quality management program and survey protocol [17].
Study setting
The Korea EMS, which is a single-tiered and government-based system, provides a basic-to-
intermediate level of ambulance services in sixteen provincial headquarters of the national fire
department and supports a population of approximately 50 million [10]. Ambulances are oper-
ated by emergency medical technicians (EMTs) who are directed not to stop CPR without on-
line medical control or declare death in field as well as during transport. Therefore, all EMS-
assessed patients are transported to the ED [18].
The Ministry of Health andWelfare designated three levels to EDs by the resources and
functional requirements according to the EMS Act; level 1 (n = 20) and level 2 (n = 130) EDs
have more resources and better facilities for emergency care and must be staffed by emergency
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physicians 24 hours a day and 365 days a year, whereas level 3 EDs (n = 310) can be staffed by
general physicians. Detailed information about EMS characteristics, OHCA protocols, ED
characteristics has been reported previously [10, 19].
Study participants
Cases were EMS-treated OHCA patients with presumed cardiac etiology who were transported
to study participating EDs from January to December 2014 and were older than 18 years of
age. OHCA patients whose arrest occurred at nursing homes or clinics and cases with
unknown information on DM were excluded.
Controls were enrolled from the Korean CHS database. Controls were randomly matched
within strata including age (10-year interval), gender, and county. Matching controls from the
same county can ensure that controls are representative sample from the same source popula-
tion. The ratio of controls to cases was 4:1; the ratio was determined in order to increase the
statistical power of the study given the infrequent nature of the event.
Measurements
Main exposure was physician-diagnosed DM prior to study enrollment and treatment method
(pharmacotherapy or non-pharmacotherapy) as measured via survey. The type of DM or prev-
alence duration were not considered. DM treatment modality was classified into four catego-
ries: insulin, oral hypoglycemic agent, non-pharmacotherapy only, and no-treatment groups.
Patients receiving combined therapy of insulin and oral hypoglycemic agent were classified as
the insulin group.
The CAPTURES project used the same questionnaire for past medical history and health
behaviors with the Korean CHS to ensure more comparable accuracy of information collected
between cases and controls. Each past medical history for both cases and controls was recorded
as “positive” if the condition was clinically recognized through physician diagnosis. We col-
lected information on date of cardiac arrest, age, gender, county, past medical history including
diagnosis of hypertension, and health behaviors including smoking (current smoker, ex-
smoker, never-smoker, and unknown), alcohol (frequent alcohol consumption (more than
twice per week), occasional alcohol consumption, never alcohol consumption, and unknown),
physical exercise (vigorous, moderate, no, and unknown), sleeping hour (0–6, 6–8, over 8
hours, and unknown), and body mass index (BMI) (10.5–18.4, 18.5–24.9, over 25.0, and
unknown).
Statistical analysis
Demographic findings of OHCA case group and community control group were described.
Continuous variables were compared using Wilcoxon rank sum test, and categorical variables
were compared using chi-square test. For the missing variables for health behaviors (smoking
(n = 274), alcohol (n = 1343), physical activity (n = 376), sleeping (n = 454), and BMI
(n = 1039)), multiple imputations with multivariable proportional logistic regression models
were conducted.
For the matched case-control dataset, multivariable conditional logistic regression analysis
was conducted to estimate the effect of diagnosis and DM treatment modality on risk of
OHCA, and to calculate the adjusted odds ratios (AORs) and 95% confidence intervals (CIs)
after controlling for potential confounders as identified in directed acyclic graph (DAG) mod-
els including past medical history and health behaviors (smoking, alcohol, physical activity,
sleeping hour, and body mass index). The variables included in the final model were examined
for multicollinearity among potential factors. No collinearity among variables was detected. All
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statistical analysis was performed using SAS software, version 9.4 (SAS Institute Inc., Cary,
NC, USA). P values are based on a two-sided significance level of 0.05.
Ethics statements
The study complies with the Declaration of Helsinki and study protocol was approved by all
Institutional Review Boards of 27 participating study institutions with waiver of informed con-
sent. This study was financially supported by the Korea Centers for Disease Control and Pre-
vention (CDC) (2013–2014).
Results
Demographic findings
Among 1,616 EMS-treated OHCAs during the study period, 1,386 patients were analyzed as
case group excluding pediatrics (n = 22), patients whose arrest occurred at clinics or nursing
homes (n = 80), and patients who had unknown information on DM (n = 128). For community
control group, 5,544 subjects were selected within strata (case to control 1:4 matching ratio)
from the 2013 Korean CHS database. A total of 1,616 matched case-control pairs were included
in the study analysis (Fig 1).
The characteristics of the OHCA case and community control groups of the original and
the imputed datasets are shown in S1 Table and Table 1. Of 1,386 OHCA patients with pre-
sumed cardiac origin, 370 (26.7%) were diagnosed with DM. Among them, 303 (81.9%)
received treatment including insulin (n = 48, 13.0%), oral hypoglycemic agent (n = 244,
65.9%), and non-pharmacotherapy only (n = 11, 3.0%); whereas among 5,544 community con-
trols, 860 (15.5%) were diagnosed with DM with 784 (91.2%) receiving treatment including
insulin (n = 75, 8.7%), oral hypoglycemic agent (n = 696, 80.9%), and non-pharmacotherapy
only (n = 13, 1.5%). We observed previous diagnosis of hypertension in 43.8% of OHCA
patients and 39.2% of community controls (p<0.01).
The demographics according to prevalence of DM and treatment method are reported in
Table 2. Diabetes patients treated with pharmacotherapy including oral hypoglycemic agent
and insulin were more likely to be older, have hypertension, less physically active, and more
obese, but less likely to be current smokers or frequent alcohol consumers than non-diabetes
study subjects (all p<0.01). Among the diabetes patients, no treatment group was most likely
to be physically active, current smoker, and frequent alcohol consumer than treatment groups.
Main analysis
Results of multivariable conditional logistic regression models including AORs (95% CIs) for
OHCA with diagnosis and treatment modality of DM are shown in Table 3. DM diagnosis was
associated with increased risk for OHCA; the AOR (95% CI) for OHCA was 1.92 (1.65–2.24)
after adjustment for other comorbidities and health behaviors. In terms of DM treatment,
AOR (95% CI) was the highest in non-pharmacotherapy only group (4.65 (2.00–10.84)), fol-
lowed by no treatment group (4.17 (2.91–5.96)), insulin group (2.69 (1.82–3.96)), and oral
hypoglycemic agent group (1.55 (1.31–1.85)).
Discussion
This case-control study, a pragmatic design for investigating relatively rare patient outcomes
such as OHCA, found that DM increased the risk of OHCA and that the risk of DM on cardiac
arrest exhibited various degrees of impact across different treatment methods. The magnitude
of risk of DM on cardiac arrest was the highest for non-pharmacotherapy and lowest for oral
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hypoglycemic agent group after adjusting for past medical history and health behaviors. With
the prevalence of DM steadily increasing temporally, intensive risk management and glycemic
control should be highlighted in order to reduce the burden of DM as well as to lower adverse
cardiovascular complications of DM.
Prevention of cardiovascular complication is crucial for diabetes patients. Intensive glyce-
mic control and the HbA1c concentration management are strongly recommended to DM
patients in order to reduce the incidence of adverse cardiovascular complications and mortality
[4, 11, 12]. However, a previous study has found that glycemic control for diabetes patients sig-
nificantly reduced the incidence of microvascular disease but had more limited effects on car-
diovascular events including arrest [20]. In this study, DM increased the overall risk of cardiac
arrest; however, the risk for OHCA in DM patients who were treated with oral hypoglycemic
agent or insulin was observed to be smaller compared to no treatment or non-pharmacother-
apy only groups. Our findings may be due to DM patients being treated with oral hypoglycemic
agent or insulin complying with doctor recommendations and regimen adherence.
Lifestyle modification such as daily physical activity, weight management, blood pressure
control, and lipid management is an additional treatment measure recommended for DM
patients in order to prevent coronary and other macrovascular disease [21]. However, our
study showed that diabetes patients were more likely to exhibit unhealthy behaviors (physical
inactivity and obesity) and hypertension, although intensive risk management is currently rec-
ommended to decrease adverse complications of DM. Furthermore, non-pharmacotherapy
only group was more likely to be obese than pharmacotherapy groups. Although a randomized
controlled study has found that an intensive lifestyle intervention focusing on weight reduction
Fig 1. Study population flow. CAPTURES: Cardiac Arrest Pursuit Trial with Unique Registration and Epidemiologic Surveillance; CHS: Community Health
Survey; EMS: emergency medical services; OHCA: out-of-hospital cardiac arrest; DM: diabetes mellitus.
doi:10.1371/journal.pone.0154245.g001
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Table 1. Demographics of out-of-hospital cardiac arrest cases and community controls.
Total OHCA cases Community controls
N (%) N (%) N (%) p-value
Total 6930 1386 5544
Gender 1.00
Female 2195 (31.7) 439 (31.7) 1756 (31.7)
Male 4735 (68.3) 947 (68.3) 3788 (68.3)
Age 1.00
19–29 130 (1.9) 26 (1.9) 104 (1.9)
30–39 320 (4.6) 64 (4.6) 256 (4.6)
40–49 755 (10.9) 151 (10.9) 604 (10.9)
50–59 1390 (20.1) 278 (20.1) 1112 (20.1)
60–69 1140 (16.5) 228 (16.5) 912 (16.5)
70- 3195 (46.1) 639 (46.1) 2556 (46.1)
Median (IQR) 67 (53–74) 68 (53–78) 67 (53–74)
Past medical history
Diabetes mellitus
Diagnosis 1230 (17.7) 370 (26.7) 860 (15.5) <0.01
Treatment 1087 (15.7) 303 (21.9) 784 (14.1) <0.01
OHA 940 (13.6) 244 (17.6) 696 (12.6) <0.01
Insulin 123 (1.8) 48 (3.5) 75 (1.4) <0.01
Hypertension
Diagnosis 2781 (40.1) 607 (43.8) 2174 (39.2) <0.01
Treatment 2543 (36.7) 522 (37.7) 2021 (36.5) 0.40
Drug 2532 (36.5) 518 (37.4) 2014 (36.3) 0.47
Health behaviors
Smoking <0.01
Current 1766 (25.5) 426 (30.7) 1340 (24.2)
Ex-smoker 2069 (29.9) 283 (20.4) 1786 (32.2)
Never smoker 3095 (44.7) 677 (48.8) 2418 (43.6)
Alcohol drink <0.01
Frequent 2294 (33.1) 387 (27.9) 1907 (34.4)
Occasional 1516 (21.9) 304 (21.9) 1212 (21.9)
Never 3120 (45.0) 695 (50.1) 2425 (43.7)
Physical activity <0.01
Vigorous 1364 (19.7) 142 (10.2) 1222 (22.0)
Moderate 1142 (16.5) 241 (17.4) 901 (16.3)
No 4424 (63.8) 1003 (72.4) 3421 (61.7)
Sleeping, hour <0.01
0–6 1371 (19.8) 205 (14.8) 1166 (21.0)
6–8 3772 (54.4) 621 (44.8) 3151 (56.8)
8- 1787 (25.8) 560 (40.4) 1227 (22.1)
Body mass index <0.01
10.5–18.4 408 (5.9) 114 (8.2) 294 (5.3)
18.5–24.9 4748 (68.5) 897 (64.7) 3851 (69.5)
25.0- 1774 (25.6) 375 (27.1) 1399 (25.2)
OHCA: out-of-hospital cardiac arrest; IQR: interquartile range; OHA: oral hypoglycemic agent
doi:10.1371/journal.pone.0154245.t001
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Table 2. Demographics according to prevalence of diabetesmellitus and level of treatment.
Total DM (-) DM and insulin DM and OHA DM and NPT DM and no treatment
N (%) N (%) N (%) N (%) N (%) N (%) p-value
Total 6930 5700 123 940 24 143
Case-Control <0.01
OHCA cases 1386 (20.0) 1016 (17.8) 48 (39.0) 244 (26.0) 11 (45.8) 67 (46.9)
Community controls 5544 (80.0) 4684 (82.2) 75 (61.0) 696 (74.0) 13 (54.2) 76 (53.1)
Gender 0.45
Female 2195 (31.7) 1786 (31.3) 42 (34.1) 319 (33.9) 6 (25.0) 42 (29.4)
Male 4735 (68.3) 3914 (68.7) 81 (65.9) 621 (66.1) 18 (75.0) 101 (70.6)
Age <0.01
19–49 1205 (17.4) 1153 (20.2) 3 (2.4) 36 (3.8) 0 (0.0) 13 (9.1)
50–59 1390 (20.1) 1216 (21.3) 19 (15.4) 128 (13.6) 5 (20.8) 22 (15.4)
60–69 1140 (16.5) 890 (15.6) 18 (14.6) 195 (20.7) 8 (33.3) 29 (20.3)
70- 3195 (46.1) 2441 (42.8) 83 (67.5) 581 (61.8) 11 (45.8) 79 (55.2)
Median (IQR) 67 (53–74) 65 (52–74) 72 (65–76) 71 (63–77) 69 (60–74) 70 (60–75)
Past medical history
Hypertension
Diagnosis 2781 (40.1) 1974 (34.6) 74 (60.2) 631 (67.1) 21 (87.5) 81 (56.6) <0.01
Treatment 2543 (36.7) 1804 (31.6) 69 (56.1) 611 (65.0) 21 (87.5) 38 (26.6) <0.01
Drug 2532 (36.5) 1796 (31.5) 69 (56.1) 608 (64.7) 21 (87.5) 38 (26.6) <0.01
Health behaviors
Smoking <0.01
Current 1766 (25.5) 1514 (26.6) 25 (20.3) 183 (19.5) 4 (16.7) 40 (28.0)
Ex-smoker 2069 (29.9) 1657 (29.1) 34 (27.6) 332 (35.3) 10 (41.7) 36 (25.2)
Never smoker 3095 (44.7) 2529 (44.4) 64 (52.0) 425 (45.2) 10 (41.7) 67 (46.9)
Alcohol drink <0.01
Frequent 2294 (33.1) 1990 (34.9) 26 (21.1) 224 (23.8) 7 (29.2) 47 (32.9)
Occasional 1516 (21.9) 1268 (22.2) 22 (17.9) 197 (21.0) 6 (25.0) 23 (16.1)
Never 3120 (45.0) 2442 (42.8) 75 (61.0) 519 (55.2) 11 (45.8) 73 (51.0)
Physical activity <0.01
Vigorous 1364 (19.7) 1191 (20.9) 10 (8.1) 127 (13.5) 4 (16.7) 32 (22.4)
Moderate 1142 (16.5) 966 (16.9) 17 (13.8) 138 (14.7) 4 (16.7) 17 (11.9)
No 4424 (63.8) 3543 (62.2) 96 (78.0) 675 (71.8) 16 (66.7) 94 (65.7)
Sleeping, hour <0.01
0–6 1371 (19.8) 1125 (19.7) 25 (20.3) 190 (20.2) 6 (25.0) 25 (17.5)
6–8 3772 (54.4) 3171 (55.6) 62 (50.4) 454 (48.3) 14 (58.3) 71 (49.7)
8- 1787 (25.8) 1404 (24.6) 36 (29.3) 296 (31.5) 4 (16.7) 47 (32.9)
Body mass index <0.01
10.5–18.4 408 (5.9) 338 (5.9) 7 (5.7) 48 (5.1) 0 (0.0) 15 (10.5)
18.5–24.9 4748 (68.5) 3951 (69.3) 67 (54.5) 624 (66.4) 14 (58.3) 92 (64.3)
25.0- 1774 (25.6) 1411 (24.8) 49 (39.8) 268 (28.5) 10 (41.7) 36 (25.2)
DM: diabetes mellitus; NPT: non-pharmacotherapy only such as nutrition or exercise; OHA: oral hypoglycemic agent; OHCA: out-of-hospital cardiac
arrest; IQR: interquartile range
*Non-pharmacotherapy included dietary intervention and physical activity prescription
doi:10.1371/journal.pone.0154245.t002
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did not reduce the rate of cardiovascular events among diabetes patients, the lifestyle prescrip-
tions were associated with glycemic control and HbA1C reduction [22].
Along with the increasing temporal trend of DM prevalence, the population attributable
risk of DM in cardiac arrest is also substantial [7]. In this study, DM was an independent risk
factor for cardiac arrest, and diabetic patients with no treatment or non-pharmacotherapy only
had a much higher risk compared to diabetic patients being treated with pharmacotherapy.
Current recommendations to prevent cardiac arrest in relation to risk management including
glucose and HbA1c management and intensive lifestyle prescriptions should be highlighted in
order to decrease the burden of cardiac arrest among patients with DM.
Limitations
This study has some limitations. First, the study design was a case-control study, not an inter-
vention trial. There may be significant potential biases that were not controlled. We selected
the control group from the same cohort of community residents who are theoretically the most
preferable as controls (population at risk). However, there was possibility of misclassification
for matching variables. Second, we measured DM by survey, and did not objectively confirm
the diagnosis using blood tests. Survey questionnaire may be interpreted differently by survey
responders, which can result in bias. Also, diagnosis of DMmay have been under- or over-esti-
mated, and it is possible that some patients had DM that was not diagnosed and therefore not
recorded in the database. Third, this study classified DM as a single dichotomous variable, and
types of DM, prevalence duration of DM, clinical manifestations, and presence of DM compli-
cations were not considered. We also did not survey why the patient selected certain treatment
methods or obtain laboratory-confirmed values of glycemic control condition including hemo-
globin A1c. The information was not available in our registry, and such factors may have
yielded different effect sizes on the study outcome. Fourth, we didn’t gather information on
past medical history of cardiovascular diseases including coronary artery disease and arrhyth-
mia. A history of different cardiovascular diseases has been linked with diagnosis and therapeu-
tic management of DM, as well as OHCA occurrence, which was not fully controlled for in this
study; the lack of information may indicate residual confounding in the main analysis. Fifth,
we made multiple imputations to process missing covariables. These factors might have not
been adjusted fully, which may have induced measurement bias. Sixth, the timeframes for the
Table 3. Multivariable conditional logistic regression analysis of diagnosis and treatment of diabetesmellitus for out-of-hospital cardiac arrest
incidence.
OHCA cases/ Community controls Unadjusted Adjusted*
n/n OR (95% CI) OR (95% CI)
Model1: DM diagnosis
No 1016 / 4684 1.00 1.00
Yes 370 / 860 2.04 (1.77–2.36) 1.92 (1.65–2.24)
Model2: DM treatment
No DM 1016 / 4684 1.00 1.00
DM and no treatment 67 / 76 4.17 (2.97–5.84) 4.17 (2.91–5.96)
Non-pharmacotherapy only 11 / 13 4.04 (1.80–9.05) 4.65 (2.00–10.84)
Oral hypoglycemic agent 244 / 696 1.66 (1.41–1.96) 1.55 (1.31–1.85)
Insulin 48 / 75 3.04 (2.10–4.40) 2.69 (1.82–3.96)
OHCA: out-of-hospital cardiac arrest; DM: diabetes mellitus; OR: odds ratio; CI: conﬁdence interval
*Adjusted for hypertension, smoking, alcohol, physical activity, sleeping hour, and body mass index.
doi:10.1371/journal.pone.0154245.t003
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case and control groups were slightly different; cases occurred during the calendar year of 2014
and controls were enrolled between September and November 2013. This difference is a poten-
tial, but likely minimal, biasing factor. Seventh, the investigators of the CAPTURES project
were not blinded to the study hypothesis, which could have led to biased data collection from
the data gatherers. Finally, the same questionnaire was used to obtain medical history and
health behaviors from both cases and controls. This minimizes one potential bias but cannot
eliminate the inherent source bias for the information on controls was presumably obtained
from the controls themselves whereas the information about cases was mainly obtained from
family members.
Conclusions
Diabetes mellitus was an important risk factor for out-of-hospital cardiac arrest. The risk of
DM on OHCA was the highest in the non-pharmacotherapy group, and the magnitude of risk
was observed to be lower in the pharmacotherapy groups. Intensive risk management should
be highlighted to reduce adverse cardiovascular complications of DM.
Supporting Information
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